MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Avalo Therapeutics (AVTX) Ownership - Who owns Avalo Therapeutics?

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
1500 Liberty Ridge Drive
Phone
+1 410 522-8707
Employees
33
Web
https://www.avalotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
937.24M
P/E Ratio
2.30
Total Cash
81.99M
Projected Growth
N/A
Total Debt
328K
Revenue
59K
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
1.56
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AVTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for AVTX
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
1500 Liberty Ridge Drive
Phone
+1 410 522-8707
Employees
33
Web
https://www.avalotx.com